Immune-Related Pneumonitis Was Decreased by Addition of Chemotherapy with PD-1/L1 Inhibitors: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (RCTs)

Purpose: Immune-related pneumonitis (IRP) has attracted extensive attention, owing to its increased mortality rate. Conventional chemotherapy (C) has been considered as an immunosuppressive agent and may thus reduce IRP’s risk when used in combination with PD-1/L1 inhibitors. This study aimed to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Yi-Xiu, Sun, Yue, Liu, Rui-Zhi, Zhang, Ming-Yi, Zhao, Jing, Wang, Yu-Qing, Zhou, Yu-Wen, Cheng, Ke, Chen, Ye, Zhu, Cai-Rong, Liu, Ji-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774972/
https://www.ncbi.nlm.nih.gov/pubmed/35049699
http://dx.doi.org/10.3390/curroncol29010025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774972/
https://www.ncbi.nlm.nih.gov/pubmed/35049699
http://dx.doi.org/10.3390/curroncol29010025

Ejemplares similares